Skip to main content

Medical In Vitro Diagnostics Technology & Solutions

In vitro diagnostics (IVD) is one of the fastest-growing areas in the medical market, driven by an aging population and the subsequent rise in associated conditions. Technology is delivering new ways to treat patients, including fully automated point -of -care (POC) instruments. These solutions are allowing healthcare providers to prescribe the precise dosage and combinations of drugs depending on the patient’s DNA and background. IVD requires highly specialized equipment and high component reliability. However, new solutions are complex and expensive to develop, and designers will need to work with manufacturers that can deliver advanced products and high-performance technology.

Overview


The world's geriatric population continues growing dramatically, prompting a related increase in the prevalence of chronic ailments and infectious disease communicability. These interdependent dynamics have prompted the need to explore more efficient, personalized and precise diagnostic approaches. Miniaturization and advancing medical technologies are presenting new opportunities to help tackle these issues. 

Consistent with ongoing, human-centered industry shifts toward remote patient monitoring and wearable medical devices, certain point-of-care diagnostic testing can now take place in either clinical settings or an individual’s home. In vitro diagnostics use a complex array of assays and reagents to identify medical conditions by analyzing a patient’s bodily fluids and/or tissue samples. All related instruments and software algorithms must work together seamlessly to make this possible—so precision design and manufacturing of complex in vitro diagnostic equipment is absolutely imperative. 

Keeping up with an ever-evolving profusion of safety, quality and regulatory guidelines in this space can be challenging for today’s manufacturers. Supply chain uncertainties, costing concerns, reimbursement models, documentation hurdles and risk mitigation challenges can often further complicate or even entirely disrupt business continuity—measurably impacting product realization initiatives and impeding time to market. 

This is why today’s leading organizations often turn to specialized, globally integrated providers who can offer knowledgeable support and state-of-the-art production efficiencies. Phillips-Medisize, a Molex company, empowers customers with 60+ years of proven product realization proficiency in the medical technology sector and across highly regulated industries. Substantial one-stop expertise with precision injection molding, high-performance medical interconnects, complex custom cable assemblies, fiber optics and more helps tomorrow’s in vitro innovations take shape today—for optimized patient care that actively improves lives around the world.

By the Numbers

Image

USD 113 Billion

In Vitro Market Size

Image

1.1 Billion

Wearable Devices Sold

Image

20%

Medtech Spend Growth


Solutions for Tomorrow’s MedTech

As computer giants and consumer manufacturers enter the medical device market, there is a huge potential for innovation. This white paper predicts the paths to success.

robot surgery machine

The Future of Medical Monitoring

Wearable devices are going to be important tools in the future of medical monitoring and diagnostics. Molex and Avnet conducted a survey amongst engineers to ask what direction these devices will take.

Image

Molex Enables Practitioner-Centered Design

Medical professionals need to have complete confidence in the devices they use. Read how Phillips-Medisize invests in technology to streamline the development of new diagnostic solutions.

Image

The Future of Mobile Devices

The MedTech industry is embracing the use of mobile devices.  Molex asked industry leaders, “what comes next?”

Image

Designing Medical Wearables for Real-Life

Next Generation Technology


FFC / FPC Connectors

Image

Quad-Row Connectors

Image

Silver Flexible Circuit Solutions

View Product
Silver-flexible-circuit-solutions